Chimeric Antigen Receptor (CAR) T-Cell Products for Pediatric Cancers: Why Alternative Development Paths Are Needed

TY - JOUR

T1 - Chimeric Antigen Receptor (CAR) T-Cell Products for Pediatric Cancers

T2 - Why Alternative Development Paths Are Needed

AU - International BFM Study Group (I-BFM), Innovative Therapies for Children with Cancer (ITCC), and the European Society for Paediatric Oncology (SIOPE)

AU - Rossig, Claudia

AU - Pearson, Andrew D

AU - Vassal, Gilles

AU - Scobie, Nicole

AU - Bird, Nick

AU - Blanc, Patricia

AU - Vormoor, H Josef

AU - Calkoen, Friso G

AU - Locatelli, Franco

AU - Bufalo, Francesca Del

AU - Rives, Susana

AU - Jacoby, Elad

AU - Balduzzi, Adriana

AU - Bourquin, Jean-Pierre

AU - Baruchel, André

PY - 2023/11/27

Y1 - 2023/11/27

UR - http://www.ncbi.nlm.nih.gov/pubmed/38011605

UR - https://www.mendeley.com/catalogue/cc1b5dad-eb46-3503-8208-724db1fc1982/

U2 - 10.1200/JCO.23.01314

DO - 10.1200/JCO.23.01314

M3 - Article

C2 - 38011605

SN - 0732-183X

SP - JCO2301314

JO - Journal of clinical oncology : official journal of the American Society of Clinical Oncology

JF - Journal of clinical oncology : official journal of the American Society of Clinical Oncology

ER -